Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic aberrations in prostate cancer by microarray analysis.

Outi R Saramäki1, Kati P Porkka, Robert L Vessella

  • 1Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere, Tampere University Hospital, Tampere, Finland.

International Journal of Cancer
|April 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of protein-coding genes associated with metastatic prostate cancer.

Endocrine-related cancer·2025
Same author

Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.

Nature communications·2024
Same author

Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer.

Cancer gene therapy·2024
Same author

Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth.

Cell reports·2024
Same author

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.

Genome medicine·2023
Same author

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.

Endocrine-related cancer·2023
Same journal

Geographical Pattern of Testicular Cancer Points to Maternal Exposures Behind Increasing Incidence.

International journal of cancer·2026
Same journal

High Endothelial Venules in Small Cell Lung Cancer: Prognostic Subtypes and Therapeutic Implications for Immunoradiotherapy.

International journal of cancer·2026
Same journal

Epigenetic Dysregulation of Somatostatin Receptors (SSTR) 1-5 and Therapeutic Implications in Neuroendocrine and Non-Neuroendocrine Malignancies.

International journal of cancer·2026
Same journal

Sex Hormone Receptors, HBV Integrations and Their Prognostic Predictive Value Among Hepatocellular Carcinoma Patients.

International journal of cancer·2026
Same journal

MET Expression in Upper Gastrointestinal Adenocarcinoma: Prevalence, Prognostic Impact, and Implications for Anti-MET Antibody-Drug Conjugate Therapy.

International journal of cancer·2026
Same journal

Leveraging Minimal Variables for Maximal Screening Yield: A Global Equity Perspective on Colorectal Cancer Risk Stratification.

International journal of cancer·2026
See all related articles

This study used high-resolution array comparative genomic hybridization (aCGH) to identify genetic alterations in prostate cancer. Findings reveal a strong link between DNA copy number changes and gene expression, impacting prostate cancer development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Prostate cancer exhibits genetic alterations, including DNA copy number variations.
  • Previous studies using chromosomal CGH (cCGH) identified common gains and losses in prostate cancer genomes.

Purpose of the Study:

  • To screen for genetic and expression alterations in prostate cancer using advanced techniques.
  • To refine the mapping of commonly altered genomic regions in prostate cancer.

Main Methods:

  • Array comparative genomic hybridization (aCGH) was performed on 5 prostate cancer cell lines and 13 xenografts.
  • DNA sequence copy number alterations were analyzed using a 16K cDNA microarray.
  • Concomitant gene expression analysis was conducted.

Related Experiment Videos

Main Results:

  • aCGH confirmed known gains (e.g., 1q, 8q, 17q) and losses (e.g., 8p, 13q, 17p) and narrowed minimal commonly altered regions.
  • A novel recurrent gain at 9p13-q21 was identified.
  • Significant association (p < 0.0001) was found between DNA copy number and gene expression levels, with specific genes like PTK2, FZD6, TNFRSF10B, and ITGA4 showing copy number-dependent expression.

Conclusions:

  • aCGH mapping data aids in identifying genes critical to prostate cancer development.
  • Combined copy number and expression analysis indicates that even minor copy number changes can significantly affect gene expression and influence prostate cancer progression.